MWP
TGTX icon

MYCIO Wealth Partners’s TG Therapeutics TGTX Stock Holding History

MYCIO Wealth Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-70,350
Closed -$781K – 348
2019
Q4 		$781K Hold
70,350
– – 0.05% 149
2019
Q3 		$395K Hold
70,350
– – 0.03% 207
2019
Q2 		$609K Hold
70,350
– – 0.05% 148
2019
Q1 		$566K Buy
70,350
+25,350
+56% +$137K 0.05% 151
2018
Q4 		$185K Sell
45,000
-25,200
-36% -$125K 0.02% 264
2018
Q3 		$393K Hold
70,200
– – 0.04% 179
2018
Q2 		$923K Buy
+70,200
New +$965K 0.1% 104

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MYCIO Wealth Partners's TGTX Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of TG Therapeutics (TGTX) in Q1 2020, closing a stake of 70,350 shares — an estimated $781K sold.

MYCIO Wealth Partners first reported a position in TGTX in Q2 2018 and held it in 7 quarters. The position peaked at $923K in Q2 2018. 146 funds tracked by Wall St. Rank hold TGTX as of Q1 2020.

  • MYCIO Wealth Partners reported no remaining TG Therapeutics position as of Q1 2020 after selling out during the quarter.
  • MYCIO Wealth Partners sold 70,350 TG Therapeutics shares in Q1 2020, an estimated $781K.
  • MYCIO Wealth Partners first reported a position in TG Therapeutics in Q2 2018 and held it in 7 quarters.
  • MYCIO Wealth Partners's TG Therapeutics position peaked at $923K in Q2 2018.
  • 146 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.